Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 1
2016 33
2017 67
2018 59
2019 69
2020 47
2021 8
Text availability
Article attribute
Article type
Publication date

Search Results

260 results
Results by year
Filters applied: . Clear all
Page 1
The Pharmacist's Expanding Role in HIV Pre-Exposure Prophylaxis.
Farmer EK, Koren DE, Cha A, Grossman K, Cates DW. Farmer EK, et al. AIDS Patient Care STDS. 2019 May;33(5):207-213. doi: 10.1089/apc.2018.0294. AIDS Patient Care STDS. 2019. PMID: 31067124 Review.
The efficacy of pre-exposure prophylaxis (PrEP) to prevent HIV has been firmly established; however, the success of PrEP largely depends on access to care as well as high levels of medication adherence. One of the key areas of focus for the National HIV/AIDS Strateg …
The efficacy of pre-exposure prophylaxis (PrEP) to prevent HIV has been firmly established; however, the success of PrEP largely depends on …
Antiretroviral Adherence Level Necessary for HIV Viral Suppression Using Real-World Data.
Byrd KK, Hou JG, Hazen R, Kirkham H, Suzuki S, Clay PG, Bush T, Camp NM, Weidle PJ, Delpino A; Patient-Centered HIV Care Model Team. Byrd KK, et al. J Acquir Immune Defic Syndr. 2019 Nov 1;82(3):245-251. doi: 10.1097/QAI.0000000000002142. J Acquir Immune Defic Syndr. 2019. PMID: 31343455 Free PMC article.
BACKGROUND: A benchmark of near-perfect adherence (95%) to antiretroviral therapy (ART) is often cited as necessary for HIV viral suppression. ...RESULTS: The adjusted odds of viral suppression did not differ between persons with an adherence level of 80% to <85% …
BACKGROUND: A benchmark of near-perfect adherence (95%) to antiretroviral therapy (ART) is often cited as necessary for HIV viral sup …
Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial.
Landovitz RJ, Li S, Grinsztejn B, Dawood H, Liu AY, Magnus M, Hosseinipour MC, Panchia R, Cottle L, Chau G, Richardson P, Marzinke MA, Hendrix CW, Eshleman SH, Zhang Y, Tolley E, Sugarman J, Kofron R, Adeyeye A, Burns D, Rinehart AR, Margolis D, Spreen WR, Cohen MS, McCauley M, Eron JJ. Landovitz RJ, et al. PLoS Med. 2018 Nov 8;15(11):e1002690. doi: 10.1371/journal.pmed.1002690. eCollection 2018 Nov. PLoS Med. 2018. PMID: 30408115 Free PMC article. Clinical Trial.
Two Grade 3 (severe) ISRs occurred in CAB recipients, 1 in each cohort, but did not lead to product discontinuation in either case. Seven incident sexually transmitted infections were diagnosed in 6 participants. One HIV infection occurred in a participant 48 weeks after l …
Two Grade 3 (severe) ISRs occurred in CAB recipients, 1 in each cohort, but did not lead to product discontinuation in either case. Seven in …
Health Care Provider Barriers to HIV Pre-Exposure Prophylaxis in the United States: A Systematic Review.
Pleuhs B, Quinn KG, Walsh JL, Petroll AE, John SA. Pleuhs B, et al. AIDS Patient Care STDS. 2020 Mar;34(3):111-123. doi: 10.1089/apc.2019.0189. Epub 2020 Feb 28. AIDS Patient Care STDS. 2020. PMID: 32109141 Free PMC article.
Six themes were identified across reviewed studies: (i) a lack of PrEP knowledge, (ii) the presence of the Purview Paradox, which refers to discordance in beliefs between HIV specialists and primary care providers on who should prescribe PrEP, (iii) concerns about PrEP costs, (iv …
Six themes were identified across reviewed studies: (i) a lack of PrEP knowledge, (ii) the presence of the Purview Paradox, which refers to …
Clinical characteristics and treatment patterns among US patients with HIV.
Priest JL, Burton T, Blauer-Peterson C, Andrade K, Oglesby A. Priest JL, et al. Am J Manag Care. 2019 Dec;25(12):580-586. Am J Manag Care. 2019. PMID: 31860226 Free article.
OBJECTIVES: Describe the clinical characteristics and treatment patterns of patients with HIV-1 who have commercial or Medicare health insurance in the United States. ...Overall, 60% of patients achieved 90% or greater adherence to their ART regimen and 16% had a pr …
OBJECTIVES: Describe the clinical characteristics and treatment patterns of patients with HIV-1 who have commercial or Medicare healt …
Disruption of latent HIV in vivo during the clearance of actinic keratosis by ingenol mebutate.
Jiang G, Maverakis E, Cheng MY, Elsheikh MM, Deleage C, Méndez-Lagares G, Shimoda M, Yukl SA, Hartigan-O'Connor DJ, Thompson GR 3rd, Estes JD, Wong JK, Dandekar S. Jiang G, et al. JCI Insight. 2019 Apr 4;4(7):e126027. doi: 10.1172/jci.insight.126027. eCollection 2019 Apr 4. JCI Insight. 2019. PMID: 30944245 Free PMC article. Clinical Trial.
Actinic keratosis (AK) is a precancerous skin lesion that is common in HIV-positive patients. Without effective treatment, AKs can progress to squamous cell carcinoma. Ingenol mebutate, a PKC agonist, is a US Food and Drug Administration-approved (FDA-approved) topical …
Actinic keratosis (AK) is a precancerous skin lesion that is common in HIV-positive patients. Without effective treatment, AKs can pr …
Pregnancy and Neonatal Outcomes Following Prenatal Exposure to Dolutegravir.
Vannappagari V, Thorne C; for APR and EPPICC. Vannappagari V, et al. J Acquir Immune Defic Syndr. 2019 Aug 1;81(4):371-378. doi: 10.1097/QAI.0000000000002035. J Acquir Immune Defic Syndr. 2019. PMID: 30939532 Free PMC article.
METHODS: We reviewed 2 large, independent antiretroviral pregnancy registries to assess birth outcomes associated with maternal dolutegravir treatment during pregnancy. RESULTS: Of 265 pregnancies reported to the Antiretroviral Pregnancy Registry, initial exposure to dolut …
METHODS: We reviewed 2 large, independent antiretroviral pregnancy registries to assess birth outcomes associated with maternal dolutegravir …
Antiretroviral therapy adherence among treatment-naive HIV-infected patients.
Chakraborty A, Qato DM, Awadalla SS, Hershow RC, Dworkin MS. Chakraborty A, et al. AIDS. 2020 Jan 1;34(1):127-137. doi: 10.1097/QAD.0000000000002384. AIDS. 2020. PMID: 31567165
OBJECTIVE: To determine the incidence of antiretroviral therapy (ART) adherence among treatment-naive HIV-infected patients and to evaluate the impact of single-tablet regimen (STR) on ART adherence among this population. ...CONCLUSION: Low ART adherence
OBJECTIVE: To determine the incidence of antiretroviral therapy (ART) adherence among treatment-naive HIV-infected patients an …
Treatment and Outcomes of Oropharyngeal Cancer in People with Human Immunodeficiency Virus.
Brickman CE, Propert KJ, Merlin JS, Liu JC, Eady S, Mcghee-Jez A, Ragin C, Grover S, Cohen RB, Gross R. Brickman CE, et al. AIDS Res Hum Retroviruses. 2019 Oct;35(10):934-940. doi: 10.1089/AID.2019.0009. Epub 2019 Aug 29. AIDS Res Hum Retroviruses. 2019. PMID: 31347379 Free PMC article.
Treatment adequacy was determined by measuring two primary endpoints associated with OPSCC survival: time to therapy and total radiation dose. ...We identified a total of 37 HIV-positive and 149 HIV-negative people with OPSCC. HIV-positive people experienced a media
Treatment adequacy was determined by measuring two primary endpoints associated with OPSCC survival: time to therapy and total
The Role of Stigma Management in HIV Treatment Adherence.
Rintamaki L, Kosenko K, Hogan T, Scott AM, Dobmeier C, Tingue E, Peek D. Rintamaki L, et al. Int J Environ Res Public Health. 2019 Dec 9;16(24):5003. doi: 10.3390/ijerph16245003. Int J Environ Res Public Health. 2019. PMID: 31835334 Free PMC article.
Social stigma is linked to improper HIV treatment adherence, but how stigma impairs adherence outcomes is poorly understood. ...Ultimately, these findings may guide intervention programs that help to entirely eliminate HIV by promoting optimized counseling an …
Social stigma is linked to improper HIV treatment adherence, but how stigma impairs adherence outcomes is poorly unders …
260 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page